Goldman Bio’s SAB
Medical experts with proven experience in the fight against cancer
March 10, 2020
Three of the members of the Scientific Advisory Board of Goldman Bio all headed and directed the oncology departments of Israel’s largest hospitals.
Read More
Appointment of special advisor for M&A and exits
March 5, 2020
Goldman Bio is proud to announce that Mr. David Gitlin is joining the company as a special advisor to the management and board on issues of M&A and exit transactions.
Read More
An article aimed at finding new strategies to prevent GBM tumor cells infiltration
February 6, 2020
MEDPNC’s Chief Scientists, Dr. Nataly Kravchenko – Balasha yesterday published, toghether with her colleagues from the Hebrew University, an article aimed at finding new strategies to prevent GBM tumor cells infiltration.
Read More
Improdia signed a cooperation agreement with Sourasky Medical Center
December 18, 2019
The Israeli diagnostics company, Improdia, has signed a cooperation agreement with Tel Aviv Sourasky Medical Center (Ichilov) to perform a large-scale clinical trial on diabetes patients aimed at preventing lethal complications based on their immune status. preventing lethal complications based on their immune status.
Read More
Diagyn and MEDPNC participated in WHII Congress
July 16, 2019
Diagyn and MEDPNC, along with other leading and innovative Israeli companies, took part in the 1st World Congress on Women’s Health Innovations and Inventions that was held at The Tel Aviv Hilton Hotel July 10-11, 2019, addressing specific unmet needs in women’s health.
The event was covered by journalists from Israel and from around the world.
Read More
Prof. Raphael D. Levine has joined MEDPNC’s Advisory Board
May 20, 2019
Raphael D. Levine is the Max Born Professor of Natural Philosophy at the Hebrew University of Jerusalem. He is a theorist, and one of the pioneers and a leader of worldwide recognition in the modern theory of chemically reactive collisions and unimolecular reactions.
Read More